Early Detection Research Network

Meltzer, Stephen

Contact Information

Email: mailto:smeltzer@jhmi.edu
Fax: 410-502-3109
EDRN Associate Member
1010
None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Polyp Prediction Study 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Barrett's Esophagus Methylation Profiles 11 1

Publications

Publication Name PubMed ID Journal
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. 16952549 Gastroenterology
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. 15107828 Oncogene
A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray. 16446548 Oncology
Aberrant methylation of Reprimo in human malignancies. 15700311 Int. J. Cancer
Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. 16108009 Int. J. Cancer
Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. 15520171 Cancer Res.
An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification. 18511875 Oncology
An unsupervised approach to identify molecular phenotypic components influencing breast cancer features. 14996713 Cancer Res.
Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma. 18425214 Bioinform Biol Insights
Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. 15221970 Int. J. Cancer
Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. 23996928 Carcinogenesis
HNPCC-associated small bowel cancer: clinical and molecular characteristics. 15765394 Gastroenterology
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. 17975140 Clin. Cancer Res.
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. 18199717 Cancer Epidemiol. Biomarkers Prev.
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. 17452981 Oncogene
Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. 15059896 Cancer Res.
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. 15824739 Oncogene
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. 11507051 Cancer Res.
Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors. 14691305 Lab. Invest.
Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. 16012936 Gastroenterology
Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma. 16837775 Oncology
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cells. 17912343 PLoS ONE
Polo-like kinase and survivin are esophageal tumor-specific promoters. 16487489 Biochem. Biophys. Res. Commun.
Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. 15545505 Ann. Surg. Oncol.
Prediction of survival in patients with esophageal carcinoma using artificial neural networks. 15751017 Cancer
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. 18729198 Int. J. Cancer
Promoter methylation and response to chemotherapy and radiation in esophageal cancer. 16678495 Clin. Gastroenterol. Hepatol.
Promoter methylation regulates cyclooxygenase expression in breast cancer. 15217498 Breast Cancer Res.
RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas. 16557577 Int. J. Cancer
Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. 17408633 Gastroenterology
Rarity of Somatic Mutation and Frequency of Normal Sequence Variation Detected in Sporadic Colon Adenocarcinoma Using High-Throughput cDNA Sequencing. 18389087 Bioinform Biol Insights
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. 17121882 Clin. Cancer Res.
Sparse logistic regression with Lp penalty for biomarker identification. 17402921 Stat Appl Genet Mol Biol
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. 15574757 Cancer Res.
Thapsigargin resistance in human prostate cancer cells. 16770788 Cancer
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. 16172218 Cancer Epidemiol. Biomarkers Prev.
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. 18382671 PLoS ONE
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. 16449976 Oncogene
Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae. 15213169 Infect. Immun.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.